A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

NCT07288567 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: KarXT
OTHER: KarXT Matching Placebo

Sponsor

Bristol-Myers Squibb